Full Episode
Sunday, Jun 4
PBS NewsHour
  • Episodes
  • Podcasts
  • Newsletters
  • The Latest
  • Politics
    Politics
    • Brooks and Capehart
    • Politics Monday
    • Supreme Court
  • Arts
    Arts
    • CANVAS
    • Poetry
    • Now Read This
  • Nation
    Nation
    • Supreme Court
    • Race Matters
    • Essays
    • Brief But Spectacular
  • World
    World
    • Agents for Change
  • Economy
    Economy
    • Making Sen$e
    • Paul Solman
  • Science
    Science
    • The Leading Edge
    • ScienceScope
    • Basic Research
    • Innovation and Invention
  • Health
    Health
    • Long-Term Care
  • Education
    Education
    • Teachers' Lounge
    • Student Reporting Labs
  • For Teachers
    Education
    • Newshour Classroom
  • NewsHour Shop
  • About
    • Feedback
    • Funders
    • Support
    • Jobs

Educate your inbox

Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.

Form error message goes here.

Thank you. Please check your inbox to confirm.

Nation
PBS NewsHour

Get news alerts from PBS NewsHour

Turn on desktop notifications?

Hepatitis-C

  • Full Episodes
  • Podcasts
  • Newsletters
  • Live
Hepatitis c virus

Health Mar 09

White House makes push to eradicate hepatitis C

By Amna Nawaz, Laura Santhanam, Dorothy Hastings

Health Mar 09

Hepatitis C positive
Hepatitis C is ‘not something you wish on anybody.’ Biden has a plan to end it

There’s no vaccine to prevent hepatitis C infections, which often go undetected for years – experts say the virus’ stealthy nature and inadequate access to testing mean that many more people likely have hepatitis C and don’t even know it.

By Laura Santhanam

Science May 23

Watch 8:30
With highest hepatitis C mortality rate in U.S., Oregon expands access to life-saving drugs

New drugs can cure up to 95 percent of patients with hepatitis C, a virus that can be debilitating or deadly. And there’s been a 20 percent rise in new infections from 2015 to 2016 due to the opioid epidemic.

By Cat Wise

Science May 23

A new clinical study is underway at 16 health centers around the country to see if a pill with an ingestible sensor can improve medication adherence rates for hepatitis C drugs. Photo by Proteus Digital Health
This digital pill wants to make following your prescription easier

Most adults say they struggle with remembering to take their prescriptions. A nationwide study is testing a pill with an ingestible sensor that tracks medication adherence from inside the body.

By Cat Wise

Health May 02

pregnant teen / pregnant woman
As opioid crisis grows, babies and moms with hepatitis C fly under the radar

Among pregnant women, the hepatitis C infection rate nearly doubled in five years, fueled primarily by injection drug use linked to the opioid crisis, and the medical community is increasingly concerned that mothers and infants may go undetected and untreated…

By Laura Santhanam

May 12

Watch 5:19
News Wrap: Cyberattack cripples institutions, companies around the world

By PBS NewsHour

In our news wrap Friday, a massive cyberattack that infected computers with ransomware crippled major institutions and companies in scores of countries. Also, the Justice Department has issued a directive to federal prosecutors to seek tougher sentences for the vast…

Continue watching

Oct 27

Bid to speed transplants with hepatitis C-infected kidneys

By Lauran Neergaard, Associated Press

WASHINGTON — Some patients facing a years-long wait for a kidney transplant are jumping ahead in line thanks to a startling experiment: They're agreeing to an organ almost sure to infect them with hepatitis C.

Continue reading

Mar 27

Watch 8:52
The Cherokee Nation wants to reverse the ‘silent epidemic’ of hepatitis C

By Stephen Fee, Mori Rothman

The Cherokee Nation, one of the largest Native American tribes, has become the first community in the U.S. to set a goal of eliminating hepatitis C from its population. Tribe officials plan to screen 300,000 members, whose prevalence of infection…

Continue watching

Dec 01

Maker of $1,000 hepatitis C pill was focused on profits, not patients, report finds

By Ricardo Alonso-Zaldivar, Associated Press

WASHINGTON — A bipartisan investigation by U.S. senators finds that the makers of a breakthrough drug for hepatitis C infection put profits before patients in pricing the $1,000-per-pill cure.

Continue reading

Nov 13

Medicare will spend $9 billion on Hepatitis-C drugs this year

By Ricardo Alonso-Zaldivar, Associated Press

Medicare spending on breakthrough medications for hepatitis C will nearly double this year, passing $9 billion, according to new government figures.

Continue reading

Jump to the First Page Previous Page
1 2
Next Page Jump to the Last Page

Support Provided By: Learn more

Educate your inbox

Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.

Form error message goes here.

Thank you. Please check your inbox to confirm.

Full Episode
Sunday, Jun 4
  • BDO
  • BNSF Railway
  • Consumer Cellular
  • Corporation for Public Broadcasting
  • Fidelity
  • Raymond James
  • Viewers Like You
  • Friends of the NewsHour
PBS NewsHour

© 1996 - 2023 NewsHour Productions LLC. All Rights Reserved.

Sections

  • The Latest
  • Politics
  • Arts
  • Nation
  • World
  • Economy
  • Science
  • Health
  • Education

About

  • About Us
  • TV Schedule
  • Press
  • Feedback
  • Funders
  • Support
  • Newsletters
  • Podcasts
  • Jobs
  • Privacy

Stay Connected

  • Facebook
  • Twitter
  • YouTube
  • RSS

Subscribe to ‘Here's the Deal,’ our politics newsletter

Form error message goes here.

Thank you. Please check your inbox to confirm.

Support our journalism

Learn more about Friends of the NewsHour.

Support for NewsHour Provided By

  • BDO
  • BNSF Railway
  • Consumer Cellular
  • Corporation for Public Broadcasting
  • Fidelity
  • Raymond James
  • Viewers Like You